c Mycobacterium massiliense has recently been proposed as a member of Mycobacterium abscessus subsp. bolletii comb. nov. Strain M154, a clinical isolate from the bronchoalveolar lavage fluid of a Malaysian patient presenting with lower respiratory tract infection, was subjected to shotgun DNA sequencing with the Illumina sequencing technology to obtain whole-genome sequence data for comparison with other genetically related strains within the M. abscessus species complex.
T
he importance of nontuberculous mycobacteria as human pathogens has been increasingly recognized in the past few decades. With improved detection methods, particularly those involving molecular analyses, new species are being identified in an expanding range of clinical material (3, 4) . There are controversies, however, in the classification of these acid-fast bacteria.
Mycobacterium massiliense, a nonpigmented fast grower, was first identified as a species within the M. abscessus complex (1). Subsequently, it was reclassified together with M. bolletii into a subspecies named M. abscessus subspecies bolletii comb. nov (6) . With the appearance of increasing numbers of genetically closely related members in the M. abscessus species, differentiation by 16S rRNA gene sequencing is no longer adequate (7). Alternative and more sophisticated sequencing platforms are needed to clarify the correct taxonomic positions of mycobacteria within the M. abscessus complex.
The erm41 gene has been shown to be a suitable marker for the differentiation of M. massiliense from other rapidly growing mycobacteria (5) . M154 was identified as M. massiliense based on the size of its erm41 gene sequence-which was identical with that of M. massiliense strain RGM134 but different from those of M. abscessus strain ATCC 19977 and M. bolletii strain KCTC 19281-as well as the presence of a truncated region in the erm41 sequence in M154 which was not present in the other two subspecies (5).
The genome of M. massiliense M154 was sequenced by using the Illumina GA 2X technology, which generated 9,920,574 reads. The sequences obtained were assembled with a commercial software, CLCBio Genomics Workbench 4.9, resulting in 44 contigs with the quality measurement of N25, contig size of 627,736, N50 contig size of 307,107 bp, and N75 contig size of 183,674 bp.
The resulting contigs were annotated using the Rapid Annotation Subsystem Technology pipeline (2) . The draft genome sequence shows a genome size of 4,801,011 bp. The automated pipeline identified 4,706 predicted coding sequences, with GϩC content of 64.2%. There are 1,506 (33% of the total) predicted coding sequences in the 375 RAST subsystems, and 45 tRNA and 3 rRNA were identified. Comparative analysis showed the top five closest neighbors of M154 to be M. abscessus, M. smegmatis strain MC2 155, Mycobacterium sp. strain MCS, Mycobacterium sp. strain JLS, and Mycobacterium sp. strain KMS, with scores of 345 to 508. These closest neighbors were achieved by blasting M154 putative genes into FIGfams, based on the isofunctional homolog property (2) .
Nucleotide sequence accession numbers. The M. massiliense strain M154 genome sequence and annotation data have been deposited in NCBI GenBank under the accession number AJMA00000000. The version described in this paper is the first version, AJMA01000000.
